化学
嘧啶
选择性
成纤维细胞生长因子受体
成纤维细胞生长因子受体1
三嗪
激酶插入结构域受体
立体化学
结构-活动关系
成纤维细胞生长因子
血管内皮生长因子受体
血管内皮生长因子
受体
生物化学
药理学
癌症研究
体外
血管内皮生长因子A
生物
催化作用
高分子化学
作者
Ikumi Kuriwaki,Minoru Kameda,Hiroyuki Hisamichi,Shigetoshi Kikuchi,Kazuhiko Iikubo,Yuichiro Kawamoto,Hiroyuki Moritomo,Yutaka Kondoh,Y. Amano,Y. Tateishi,Yuka Echizen,Yoshinori Iwai,Atsushi Noda,Hiroshi Tomiyama,Tomoyuki Suzuki,Masaaki Hirano
标识
DOI:10.1016/j.bmc.2020.115453
摘要
Fibroblast growth factor receptor 3 (FGFR3) is an attractive therapeutic target for the treatment of bladder cancer. We identified 1,3,5-triazine derivative 18b and pyrimidine derivative 40a as novel structures with potent and highly selective FGFR3 inhibitory activity over vascular endothelial growth factor receptor 2 (VEGFR2) using a structure-based drug design (SBDD) approach. X-ray crystal structure analysis suggests that interactions between 18b and amino acid residues located in the solvent region (Lys476 and Met488), and between 40a and Met529 located in the back pocket of FGFR3 may underlie the potent FGFR3 inhibitory activity and high kinase selectivity over VEGFR2.
科研通智能强力驱动
Strongly Powered by AbleSci AI